| |
Group 1 |
Group 2 |
| |
Before treatment |
After treatment |
△ |
P |
Before treatment |
After treatment |
△ |
P |
| eGFR (ml/min) |
98.3 ± 19.8 |
128.1 ± 16.3 |
30.2 ± 19.1 |
0.02 |
29.8 ± 14.7 |
76.8 ± 24.6 |
36.1 ± 32.1 |
0.02 |
| S.Creatinine(mg%) |
0.9 ± 0.2 |
0.6 ± 0.1 |
-0.3 ± 0.2 |
0.03 |
4.1 ± 1.7 |
2.5 ± 1.4 |
-1.6 ± 1.6 |
0.01 |
| UAE |
70.1 ± 50.2 |
45.6 ± 42.3 |
-25.3 ± 48.8 |
0.009 |
1287.6 ± 135.5 |
771.3 ± 125.6 |
-514 ± 132.2 |
0.008 |
(p<0.05 is significant). The difference in delta values of means before and after treatment was done using Wilcoxon t-test. Group 1: type 2 diabetes without nephropathy, Group 2: type 2 diabetes with nephropathy. |
